Products

Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.

Connect With Us

All Products (326)

Quick filters: Solid Tumour Hematologic Both Name A-Z Name Z-A

Therapeutic Areas

Sort by

Clear all filters

Molecule	Drug Class / Mechanism	Oncology Type
Axitinib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Axitinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Regorafenib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Regorafenib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Cabozantinib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Cabozantinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Lenvatinib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Lenvatinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Vatalanib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Vatalanib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Tivozanib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Tivozanib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Nintedanib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Nintedanib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Ripretinib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Ripretinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Avapritinib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Avapritinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Anlotinib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Anlotinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Surufatinib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Surufatinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Fruquintinib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Fruquintinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor

Axitinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Regorafenib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Cabozantinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Lenvatinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Vatalanib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Tivozanib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Nintedanib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Ripretinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Avapritinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Anlotinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Surufatinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Fruquintinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor

‹ 1 … 3 4 5 6 7 … 28 ›

Product Range

Company

Global Network

Products

Axitinib

Regorafenib

Cabozantinib

Lenvatinib

Vatalanib

Tivozanib

Nintedanib

Ripretinib

Avapritinib

Anlotinib

Surufatinib

Fruquintinib

Axitinib

Regorafenib

Cabozantinib

Lenvatinib

Vatalanib

Tivozanib

Nintedanib

Ripretinib

Avapritinib

Anlotinib

Surufatinib

Fruquintinib